Management of acute heart failure: Contribution of daily bedside echocardiographic assessment on therapy adjustment with impact measure on the 30-day readmission rate (JECICA)

Jean-Etienne Ricci, Eran Kalmanovich, Christelle Robert, Thierry Chevallier, Sylvain Aguilhon, Kamila Solecki, Mariama Akodad, Luc Cornillet, Camille Soullier, Guillaume Cayla, Benoit Lattuca, François Roubille, Jean-Etienne Ricci, Eran Kalmanovich, Christelle Robert, Thierry Chevallier, Sylvain Aguilhon, Kamila Solecki, Mariama Akodad, Luc Cornillet, Camille Soullier, Guillaume Cayla, Benoit Lattuca, François Roubille

Abstract

There are currently one million heart failure (HF) patients in France and the rate is progressively increases due to population aging. Acute decompensation of HF is the leading cause of hospitalization in people over 65 years of age with a 25% re-hospitalization rate in the first month. Expenses related to the management of HF in France in 2013 amounted to more than one billion euros, of which 65% were for hospitalizations alone. The management of acute decompensation is a challenge, due to the complexity of clinical and laboratory evaluation leading to therapeutic errors, which in turn leads to longer hospitalization, high early re-hospitalization and complications. Therapeutic adjustment, especially diuretic, in the acute phase (during hospitalization) affects early re-hospitalization rates (within 30 days). These adjustments can be based on clinical estimation and laboratory parameters, but echocardiography has been shown to be superior in estimating filling pressures (FP) compared to clinical and laboratory parameters. We hypothesize that a simple daily bedside echocardiographic assessment could provide a reproducible estimation of FP with an evaluation of mitral inflow and the inferior vena cava (IVC). This could allow a more reliable estimate of the true blood volume of the patient and thus lead to a more suitable therapeutic adjustment. This in turn should lead to a decrease in early re-admission rate (primary endpoint) and potentially decrease six-month mortality and rate of complications.

Keywords: Cava venous; Diuretics; Doppler echocardiography; Filling pressure; Heart failure; Left ventricular ejection fraction; Trans-mitral doppler.

Figures

Fig. 1
Fig. 1
Study design of the JECICA Trial.
Fig. 2
Fig. 2
Algorithm of JECICA trail treatment in the DE arm.

References

    1. Farmakis D., Parissis J., Lekakis J. Acute heart failure: Epidemiology, risk factors, and prevention. Rev. Esp. Cardiol. 2015 Mar;68(3):245–248. PubMed PMID: 25659507; eng.
    1. Tuppin P., Cuerq A., de Peretti C. Two-year outcome of patients after a first hospitalization for heart failure: a national observational study. Arch Cardiovasc. Dis. 2014 Mar;107(3):158–168.
    1. Cook C., Cole G., Asaria P. The annual global economic burden of heart failure. Int. J. Cardiol. 2014 Feb 15;171(3):368–376.
    1. Ross J.S., Chen J., Lin Z. Recent national trends in readmission rates after heart failure hospitalization. Circ. Heart Fail. 2010 Jan;3(1):97–103. PubMed Central PMCID: PMCPMC2830811. eng.
    1. Feltner C., Jones C.D., Cene C.W. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann. Intern. Med. 2014 Jun 3;160(11):774–784.
    1. Maggioni A.P. Epidemiology of heart failure in Europe. Heart Fail. Clin. 2015 Oct;11(4):625–635.
    1. Bello N.A., Claggett B., Desai A.S. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ. Heart Fail. 2014 Jul;7(4):590–595. PubMed PMID: 24874200; PubMed Central PMCID: PMCPMC4102617. eng.
    1. Lavine K.J., Mann D.L. Rethinking phase II clinical trial design in heart failure. Clin. Invest. 2013 Jan 1;3(1):57–68. PubMed Central PMCID: PMCPMC4204480. eng.
    1. Lala A., McNulty S.E., Mentz R.J. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF) Circ. Heart Fail. 2015 Jul;8(4):741–748. PubMed Central PMCID: PMCPMC4512849. eng.
    1. Heidenreich P.A., Hernandez A.F., Yancy C.W. Get with the Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure. Circ. Cardiovasc. Qual. Outcomes. 2012 Jan;5(1):37–43. PubMed PMID: 22235067; eng.
    1. Gorthi J., Hunter C.B., Mooss A.N. Reducing heart failure hospital readmissions: a systematic review of disease management programs. Cardiol. Res. 2014 Oct;5(5):126–138. PubMed Central PMCID: PMCPMC5358117. eng.
    1. Adamson P.B., Abraham W.T., Stevenson L.W. Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circ. Heart Fail. 2016 Jun;9(6)
    1. Weintraub N.L., Collins S.P., Pang P.S. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010 Nov 9;122(19):1975–1996.
    1. Parrinello G., Torres D., Paterna S. The challenge of the volume status assessment in heart failure. Am. Heart J. 2009;157:e19–20. United States. author reply e21.
    1. Remes J., Miettinen H., Reunanen A. Validity of clinical diagnosis of heart failure in primary health care. Eur. Heart J. 1991 Mar;12(3):315–321. eng.
    1. Ronco C., Cicoira M., McCullough P.A. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J. Am. Coll. Cardiol. 2012 Sep 18;60(12):1031–1042.
    1. Metra M., Cotter G., Gheorghiade M. The role of the kidney in heart failure. Eur. Heart J. 2012 Sep;33(17):2135–2142.
    1. Ponikowski P., Voors A.A., Anker S.D. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016;37(27):2129–2200. 2016 Jul 14.
    1. Binanay C., Califf R.M., Hasselblad V. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. Jama. 2005 Oct 5;294(13):1625–1633.
    1. Nagueh S.F., Bhatt R., Vivo R.P. Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure. Circ. Cardiovasc. Imag. 2011 May;4(3):220–227.
    1. Galderisi M., Lancellotti P., Donal E. European multicentre validation study of the accuracy of E/e' ratio in estimating invasive left ventricular filling pressure: EURO-FILLING study. Eur. Heart J. Cardiovasc. Imag. 2014 Jul;15(7):810–816.
    1. Vitarelli A., Gheorghiade M. Transthoracic and transesophageal echocardiography in the hemodynamic assessment of patients with congestive heart failure. Am. J. Cardiol. 2000 Aug 17;86(4a):36g–40g. (eng)
    1. Lei J., Dhamoon A.S., Wang J. Walking the tightrope: using quantitative Doppler echocardiography to optimize ventricular filling pressures in patients hospitalized for acute heart failure. Eur. Heart J. Acute Cardiovasc. Care. 2016 Apr;5(2):130–140.
    1. Goonewardena S.N., Spencer K.T. Handcarried echocardiography to assess hemodynamics in acute decompensated heart failure. Curr. Heart Fail. Rep. 2010 Dec;7(4):219–227.
    1. Nguyen V.T., Ho J.E., Ho C.Y. Handheld echocardiography offers rapid assessment of clinical volume status. Am. Heart J. 2008 Sep;156(3):537–542.
    1. Wiley B., Mohanty B. Handheld ultrasound and diagnosis of cardiovascular disease at the bedside. J. Am. Coll. Cardiol. 2014 Jul 15;64(2):229–230.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel